FindTrial
Sign In

Testing a New Grading System to Select the Right Patients for Robotic Pancreatic Surgery - A multinational observational study

Validation of the ISGPS Minimally Invasive Pancreatoduodenectomy complexity and competency grading system- A nationwide snapshot study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087078
Enrollment
1000
Registered
2025-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K869- Disease of pancreas, unspecified

Interventions

Intervention1: Not applicable: Not applicable Control Intervention1: Not applicable: Not applicable

Sponsors

University of Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients treated with robot-assisted pancreatoduodenectomy for all indications between 2014 and 2023 will be included.

Exclusion criteria

Exclusion criteria: Patients who underwent open or laparoscopic pancreatoduodenectomy will be excluded.

Design outcomes

Primary

MeasureTime frame
The primary outcome is major complication rate (Clavien-Dindo 3 or higher) and PORSCH outcome.Timepoint: From date of surgery to date of discharge—

Secondary

MeasureTime frame
Secondary outcomes are pancreas specific complications (POPF, PPH, DGE, bile leak) according to the ISGPS and ISGLS classification systems.Timepoint: From date of surgery to date of discharge—

Countries

India, Netherlands

Contacts

Public ContactDr Shailesh Shrikhande

TATA MEMORIAL HOSPITAL

shailushrikhande@hotmail.com9820224761

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026